Insulin‐like growth factor binding protein‐4: The quest for the breakthrough biomarker in pulmonary arterial hypertension
Energy metabolism pathways and their association with cell proliferation and growth have been related to PAH, in particular the insulin-like growth factor (IGF) axis pathways. High-throughput plasma proteome analysis in PAH patients has identified proteins that correlate to survival, identifying the...
Saved in:
Published in | Pulmonary circulation Vol. 13; no. 2; pp. e12252 - n/a |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.04.2023
John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Energy metabolism pathways and their association with cell proliferation and growth have been related to PAH, in particular the insulin-like growth factor (IGF) axis pathways. High-throughput plasma proteome analysis in PAH patients has identified proteins that correlate to survival, identifying the insulin-growth factor binding protein-1 (IGFBP-1) as one of them. Subgroup analysis revealed that regardless of PAH subtype, above median IGFBP-4 levels were associated with worsening survival rates. Sandeep Sahay: Grants/Research Support: Research grant from United Therapeutics; Consultant: United Therapeutics, J&J, Bayer, Gossamer Bio, Liquidia technologies, Keros; Speaker's Bureau: Janssen, United Therapeutics (honorarium received by Houston Methodist Hospital Foundation); Clinical trial support from United Therapeutics, Janssen, Gossamer Bio, Altavant Sciences, Liquidia technologies, Novartis, Keros. |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1 |
ISSN: | 2045-8940 2045-8932 2045-8940 |
DOI: | 10.1002/pul2.12252 |